MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹3.66 Cr | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹7.26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹3.66 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹7.26 Cr |
How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.66 Cr | -65.52 | |
| Mar2024 | ₹11 Cr | -30.98 | |
| Mar2023 | ₹15 Cr | 11.78 | |
| Mar2022 | ₹14 Cr | 89.48 | |
| Mar2021 | ₹7.26 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹11,606.5 Cr | 3.5% | 18.5% | 0.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 3.5% |
18.5% |
0.8% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses